These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2658727)

  • 1. Immunohistological studies in five patients with unknown primary carcinomas and poorly differentiated neoplasms.
    Greenberg BR
    Ann Clin Lab Sci; 1989; 19(3):175-83. PubMed ID: 2658727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining.
    Hainsworth JD; Wright EP; Johnson DH; Davis BW; Greco FA
    J Clin Oncol; 1991 Nov; 9(11):1931-8. PubMed ID: 1941051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential diagnosis of occult primary malignant melanoma].
    Friedrich T; Horn LC; Pönitzsch I; Reichel MB; Schönfelder M
    Zentralbl Chir; 1999; 124(6):495-500. PubMed ID: 10436506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neck nodal metastases from unknown primary: case series.
    Tamiolakis D; Chimona TS; Proimos E; Georgiou G; Perogamvrakis G; Papadakis CE
    Chirurgia (Bucur); 2008; 103(3):331-5. PubMed ID: 18717284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary and pleural metastases in malignant melanoma].
    Wiebe T; Wetzer K
    Z Erkr Atmungsorgane; 1986; 167(1-2):145-51. PubMed ID: 3765709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
    Hainsworth JD; Greco FA
    Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfall.
    Nandedkar MA; Palazzo J; Abbondanzo SL; Lasota J; Miettinen M
    Mod Pathol; 1998 Dec; 11(12):1204-10. PubMed ID: 9872653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
    Greco FA; Hainsworth JD
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical diagnosis of metastases of small round cell carcinomas with undetected primary focus].
    Savelov NA; Petrovichev NN; Anurova OA; Pavlovskaia AI; Tatosian AG
    Arkh Patol; 2006; 68(2):16-9. PubMed ID: 16752503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
    Lane Z; Epstein JI; Ayub S; Netto GJ
    Hum Pathol; 2008 Apr; 39(4):543-9. PubMed ID: 18234278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of the immunohistochemical exam in the diagnosis of the secondary malignant tumors to the thyroid gland.
    Ciobanu D; Vulpoi C; Găluşcă B; Florea N; Giuşcă SE; Căruntu ID
    Rom J Morphol Embryol; 2007; 48(2):113-9. PubMed ID: 17641797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
    Ben-Arie A; Huszar M; Ben-Zvi N; Smirnov A; Altevogt P; Fogel M
    Eur J Surg Oncol; 2008 Jul; 34(7):795-9. PubMed ID: 17845837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancers of unknown origin: 311 cases].
    Lortholary A; Abadie-Lacourtoisie S; Guérin O; Mege M; Rauglaudre GD; Gamelin E
    Bull Cancer; 2001 Jun; 88(6):619-27. PubMed ID: 11459709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
    Onofre AS; Pomjanski N; Buckstegge B; Böcking A
    Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing carcinomas of unknown primary site.
    Hainsworth JD; Greco FA
    Oncology (Williston Park); 1988 Jul; 2(7):43-9, 52-4. PubMed ID: 3275052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unknown primary cancer].
    Furue H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers.
    Kulshrestha R; Vijayan VK
    Indian J Chest Dis Allied Sci; 2009; 51(1):21-5. PubMed ID: 19317359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.